Chromatography
Peptide Sample Analysis Using EternityXT
Mar 16 2018
The peptide therapeutic market continues to develop fast where pharmaceutical companies focus in these types of compounds for large number of diseases. Chromatography plays an important role across the entire drug development cycle. Kromasil EternityXT, chemically stable merged inorganic/organic silica material for reversed phase chromatography, is a perfect material to be used from analysis to scale up of peptides.
With excellent mechanical and chemical stability, the Kromasil EternityXT materials offer first-rate separation power as well as loadability at low, medium and high pH. EternityXT columns are provided in 1.8 µm particles for UHPLC, 2.5 µm particles for both UHPLC and HPLC applications and finally 5 µm particles for HPLC and semipreparative chromatography. The C18 and C8 chemistries are also available in bulk for purification. The Kromasil EternityXT columns are based on patented technology, resulting from 30 years of expertise and used by chromatographers worldwide.
Digital Edition
LMUK 49.7 Nov 2024
November 2024
Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Handling - Clinical, Medical & Diagnostic Products News...
View all digital editions
Events
Nov 11 2024 Dusseldorf, Germany
Nov 12 2024 Cologne, Germany
Nov 12 2024 Tel Aviv, Israel
Nov 18 2024 Shanghai, China
Nov 20 2024 Karachi, Pakistan